Hosted by Psymposia · 🇺🇸 US · EN · 84 episodes
Established thought leaders with verified media credentials.
Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction. We offer critical perspectives on drugs, politics, and culture.The podcast is co-hosted by Psymposia co-founder Brian Normand, psychedelics researcher and ethicist Neşe Devenot, evolutionary ecologist Brian Pace, and journalist Russell Hausfeld.
Psymposia hosts The Psymposia Podcast, a society show with 84 episodes published.
This is an excerpted interview from episode #74. Psymposia speaks with Jane Migliara Brigham of The Needle to discuss her recent article, "Ambetter Insurance, Centene denying hormones to trans patients across 19 states i
James, Russell, and Normie chat about the Best in Grass competition before diving into a discussion of a lawsuit against OpenAI over alleged bad drug advice and the preservation of the Terence McKenna archive. Russell co
SUPPORT: https://www.patreon.com/psymposia FOLLOW: https://www.instagram.com/psymposia/ https://x.com/psymposia https://bsky.app/profile/psymposia.bsky.social Normie, Neşe, Russell, and James dive into the telehealth sup
We have made some changes to our Patreon and wanted to let you know what to expect from your subscription moving forward! Simplified Tiers. We simplified our tiers so there will only be three offerings: a $5, $10, and $5
This clip from our Patreon bonus content breaks down the so-called "pentastack" behind looksmaxxer streams: a combinations of stimulants, dissociatives, performance drugs, and psychiatric medications. We also examine the
Russell, Normie, Pace and James debut a new podcast format covering the latest developments in psychedelics, drug policy, and politics. Today, they review the latest Church of Sacred Synthesis lawsuit news, misperception
Psymposia board member Dr. Neşe Devenot's presentation at the Ohio State University "Religion and Psychedelics" conference, recorded March 28, 2026. In this talk, Dr. Devenot presents their research on the reliance on un
Professor Dave is a well-known science communicator and prolific debunker of pseudoscience. Despite building his platform on combatting misinformation, he continues joining conversations that promote false claims about t
Three psychedelic companies received vouchers for expedited FDA review: Usona, Compass Pathways, and Otsuka—NOT Resilient Pharmaceuticals. This voucher announcement is yet another vindication of our reporting on major pr
Psychedelics are the next front in Big Tech's dystopia. Psymposia developed this primer for leftists in response to Donald Trump's April 18 Executive Order, which accelerates review of psychedelic drugs deemed "Breakthro
It has become a problematic standard practice in the psychedelic therapy industry to increase drug dosages after patients display red flag symptoms. Psymposia discusses a recent Wall Street Journal article about these pr
In this final episode, we explore the attempts made by Hamilton Morris to attack the work, integrity, and character of our team.
Psymposia discusses Hamilton Morris's misinformation about their funding, his relationship with Compass Pathways, his claims that the nonprofit Usona has planted protestors at conferences to make him look bad, and claims
Psymposia discusses their history with the Church of Psilomethoxin and addresses Hamilton Morris's misinformation about their funding and the alleged elder abuse of psychedelic funder George Sarlo by MAPS Board Chair Vic
Psymposia addresses Hamilton Morris's misinformation, including his speculation that they are DEA informants, their behavior at the FDA advisory committee for Lykos' Therapeutics' MDMA application, and more.
Psymposia discusses more notable psychedelic figures who have turned up in the Epstein files — including Paul Krassner, Rupert and Merlin Sheldrake, Paul Daley, and more. 2:06: Kimbal Musk updates 4:48: Ken Jordan/Alchem
Psymposia discusses notable psychedelic figures who have turned up in the Epstein files — including major funders and investors Austin Hearst, Steve Jurvetson, and Kimbal Musk. 02:31: Austin Hearst 10:18: Steve Jurvetson
Psymposia discusses flaws in Andrew Callaghan's journalism, his response to sexual abuse allegations, and how it relates to our experience as the subjects of targeted reporting from Channel 5. 1) Two Women Accuse Documen
Psymposia senior writer Russell Hausfeld sits down with author Bitter Karella to discuss their debut novel "Moonflow," their micro-fiction and text adventure projects, psychedelic mushrooms, writing queer and trans horro
On June 6, Psymposia reported on the presenter contract for MAPS' Psychedelic Science 2023. The contract includes clauses that limit when and where presenters can speak, and a "MAPS Reputation" clause that warns speakers
Hamilton Morris
journalist and chemist · Hamilton's Pharmacopeia
2 appearances on this show
Merlin Sheldrake
Biologist & Bestselling Author of “Entangled Life: How Fu...
1 appearance on this show
Paul Daley
Chief Science Officer, Chemist · Alexander Shulgin Research Institute
1 appearance on this show
Rupert Sheldrake
biologist and author
1 appearance on this show
Andrew Callaghan
host of Channel 5 news YouTube channel · Channel 5
1 appearance on this show
Bitter Karella
author of the trippy trans horror novel "Moonflow"
1 appearance on this show
Greg Lake
speaker · Church of Psilomethoxin
1 appearance on this show
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
The Psymposia Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their society audience.
The Psymposia Podcast is hosted by Psymposia. The show is categorised under society (culture) and has published 84 episodes.
The Psymposia Podcast has published 84 episodes.
The Psymposia Podcast regularly covers society, culture, education. It sits in the society category, with a culture focus.
The Psymposia Podcast is accessible for guests with genuine society expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
The Psymposia Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of The Psymposia Podcast average 51 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates The Psymposia Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 10 days ago.
